Poly Medicure Ltd - 531768 - Statement Of Investor Complaints For The Quarter Ended June 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- AVINASH CHANDRADesignation :- Company Secretary and Compliance Officer POLY MEDICURE LTD. - 531768 - Closure of Trading Window
It may please be noted that in compliance with the SEBI (Prohibition to Insider Trading) Regulations, 2015 as amended by the SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018 read with clarification given by BSE Circular Ref No.: LIST/COMP/01/2019-20 dated 02.04.2019 and NSE letter ref no: NSE/CML/2019/11 dated 02.04.2019 read with Company''s Code of Conduct for prevention of Insider Trading, the Trading Window of the Company has been kept closed for designated person from Monday, the 1st July, 2019 till the end of 48 hours after the declaration of Financial Results for the quarter ended on 30th June, 2019. The date of the Board Meeting to consider the above financial results would be intimated to the Stock Exchange in due course. You are hereby requested to please take the above information on your records. Poly Medicure Ltd - 531768 - Disclosure Of Related Party Transactions For The Half Year Ended On 31St March, 2019 Under Regulation 23(9) Of SEBI (LODR) Regulations, 2015
Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, pleased find enclosed herewith disclosure of Related Party Transactions drawn in accordance with applicable Accounting Standards for the half-year ended on 31st March, 2019. Kindly take a note of the same for your further needful and oblige us. POLY MEDICURE LTD. - 531768 - Declaration Of Impact Of Un-Modified Audit Qualifications (Standalone & Consolidated)
Dear Sir/Madam, In Compliance of Regulation 33(3)(d) of SEBI (LODR) Regulations, 2015, We hereby declare that M/s. Doogar & Associates (Statutory Auditors) of the Company have issued Audit Report with un-modified opinion on the Audited Financial Results (Standalone & Consolidated) for the fourth quarter and financial year ended on 31st March, 2019. Kindly take a note of the same for your further needful and oblige us. POLY MEDICURE LTD. - 531768 - Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report Sr. No. Particulars Details 1Period for which the report has been issued 31/03/2019 2Date of Report28/05/2019 3 Name of the Certifying Firm B K Sethi & Company 4 Name of the Certifying Individual Balraj Krishan Sethi 5Membership TypeFCS 6 Membership Number 853 7 CP No. 913 8 Whether any observations/qualification reported by the Secretarial Auditor ? NO POLY MEDICURE LTD. - 531768 - Board recommends Dividend
Poly Medicure Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 10, 2019, inter alia, has approved the following business:- Recommendation of Dividend of Rs. 2 (Two Rupee) per Equity Shares (40%) of Rs. 5 each for the Financial Year 2018-19, subject to approval of shareholders. POLY MEDICURE LTD. - 531768 - Outcome of Board Meeting
Dear Sir/Madam, Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, We are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. 10th May, 2019, at EROS Hotels, Nehru Place, New Delhi - 110019, approved the following businesses: a) Audited Financial Results (Consolidate & Standalone) for the year ended on 31st March 2019. b) Recommendation of Dividend of Rs. 2 (Two Rupee) per Equity Shares (40%) of Rs. 5 each for the Financial Year 2018-19, subject to approval of shareholders. c) allotment of 10,050 Equity Shares of Rs. 5 each, pursuant to exercise of an option under Employee Stock Option Scheme, 2015. Kindly take a note of the same for your further needful and oblige us. POLY MEDICURE LTD. - 531768 - Board to consider Dividend
Poly Medicure Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 10, 2019, inter alia, to consider the following:1. To consider and approve the Audited Financial Results (Consolidated & Standalone) of the Company for the financial year ended on March 31, 2019.2. To consider recommendation of Dividend, if any, on the Equity Shares for the financial year ended on March 31, 2019. POLY MEDICURE LTD. - 531768 - Board Meeting Intimation for Intimation Of Notice Of Board Meeting To Be Held On 10Th May, 2019
POLY MEDICURE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/05/2019 ,inter alia, to consider and approve Pursuant to Regulation 29(1)(a) of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, notice is hereby given that a meeting of the Board of Directors of the Company will be held on Friday, the 10th May, 2019, inter alia to consider the following: a) To consider and approve the Audited Financial Results (Consolidated & Standalone) of the Company for the financial year ended on 31st March, 2019. b) To consider recommendation of Dividend, if any, on the Equity Shares for the financial year ended on 31st March, 2019. c) To transact any other matter which the Board may deem fit. This is for your information and record.